Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas.

Source:http://linkedlifedata.com/resource/pubmed/id/1688617

Download in:

View as

General Info

PMID
1688617